Hubei Hendi Pharmaceutical Co., Ltd. was renamed from Hubei Baike Hendi Pharmaceutical Co., Ltd. on June 28th, 2020. Mainly engaged in research and development, production and sales of pharmaceutical raw materials and preparation products. R&D and sales center are located in Wuhan. The company has three subsidiaries: Wuhan Baike Pharmaceutical Development Co., Ltd., Wuhan Hendi Pharmaceutical Development Co., Ltd. and Hubei Baike Pharmaceutical Trading Co., Ltd. 1 Subsidiary: Institute Branch of Hubei Hendi Pharmaceutical Co., Ltd.
Hubei Baike Hendi Pharmaceutical Co., Ltd. is the largest supplier of ibuprofen, a non-steroidal anti-inflammatory drug, in China and the second largest in the world. Is a company specializing in high-end chemical raw materials and preparations.
The company is a high-tech enterprise in Hubei Province, a postdoctoral innovation practice base in Hubei Province, the fourth batch of hidden champion enterprises in Hubei Province, the pharmacy teaching base of Tongji Medical College of Huazhong University of Science and Technology, and one of the six key enterprises in COVID-19, Hubei Province in 2020.
The company insists on taking raw materials as the core, doing better and stronger, building the company into an important production base of non-steroidal anti-inflammatory drugs and characteristic raw materials in China, and will make further efforts to lay out the CDMO and preparation business of raw materials, so as to realize the coordinated development of raw materials and preparations.